Moneycontrol
Get App
Last Updated : Oct 14, 2019 04:07 PM IST | Source: Moneycontrol.com

Glenmark Q2 PAT may dip 46% YoY to Rs. 132.8 cr: Emkay

Net Sales are expected to increase by 2.4 percent Y-o-Y (up 13.8 percent Q-o-Q) to Rs. 2,642.7 crore, according to Emkay.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Emkay has come out with its second quarter (July-September’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Glenmark to report net profit at Rs. 132.8 crore down 46% year-on-year (up 22% quarter-on-quarter).


Net Sales are expected to increase by 2.4 percent Y-o-Y (up 13.8 percent Q-o-Q) to Rs. 2,642.7 crore, according to Emkay.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 16 percent Y-o-Y (up 9 percent Q-o-Q) to Rs. 371.7 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Oct 14, 2019 04:07 pm
Sections
Follow us on